Tanshinone IIA may have a significant role in regulating synaptic plasticity, implying that the pharmacological mechanism of tanshinone IIA in cognitive disorders of epilepsy may be connected to enhanced PSD-95 and SYN expression and improved synaptic plasticity in the hippocampus. The gene discussed is DLG4; the disease is cognitive disorder.